Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma
- 1 July 1994
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 1 (4) , 333-338
- https://doi.org/10.1007/bf03187139
Abstract
Background: Interstitial fluid pressure (IFP) in rodent malignant tumors is reportedly much higher than in surrounding normal tissue. We hypothesized the same may be true in human invasive breast tumors. Methods: We measured IFP in the operating room in 25 patients undergoing excision breast biopsy under local anesthetic for diagnostic purposes. Results: In patients with invasive ductal carcinomas IFP was 29 ± 3 (SE) mm Hg, compared with −0.3 ± 0.1 mm Hg in those with normal breast parenchyma (p < 0.001), 3.6 ± 0.8 mm Hg in those with benign tumors (p < 0.003), −0.3 ± 0.2 mm Hg in those with noninvasive carcinomas (p = 0.034), and 0.4 ± 0.4 mm Hg in those with other benign breast conditions (p = 0.002). There was a direct correlation between IFP and tumor size (R 2 = 0.3977; p = 0.021). No correlation was found between IFP and nuclear grade, angiolymphatic invasion, systemic blood pressure, metastasis to lymph nodes, or estrogen and progesterone receptors. Conclusions: IFP measurements may facilitate radiographic or ultrasound localization of small or nonpalpable malignant tumors in those patients undergoing needle aspiration cytology or stereotactic core needle biopsy.Keywords
This publication has 14 references indexed in Scilit:
- Interstitial hypertension in human breast and colorectal tumors.1992
- Evaluation of a Palpable Breast MassNew England Journal of Medicine, 1992
- Interstitial hypertension in head and neck tumors in patients: correlation with tumor size.1992
- Interstitial hypertension in superficial metastatic melanomas in humans.1991
- Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response.1991
- INTERSTITIAL PRESSURE-GRADIENTS IN TISSUE-ISOLATED AND SUBCUTANEOUS TUMORS - IMPLICATIONS FOR THERAPY1990
- Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and StrategiesJNCI Journal of the National Cancer Institute, 1989
- Transport of molecules in the tumor interstitium: a review.1987
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983
- ORGAN VASCULARITY AND METASTATIC FREQUENCY1980